Stock Screener App

無料 - Play StoreApp Store

インストールインストール

PRAX

$280.512.38%6.52

プレマーケット: 283.00+2.49 +0.89%

Praxis Precision Medicines Inc (PRAX)

Date: O: H: L: C: Vol:

Praxis Precision Medicines Inc (PRAX) 最新ニュース

Aspen Neuroscience Announces Pricing of Initial Public Offering - Yahoo Finance

Praxis Precision Medicines, Inc. Common Stock (PRAX) - Milk Road

Praxis Precision Medicines (NasdaqGS:PRAX) Stock Forecast & Analyst Predictions - Simply Wall Street

Praxis and Remagine partner to develop ulixacaltamide patch - scanx.trade

Praxis grants 951 RSUs to new employees under inducement plan - scanx.trade

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance UK

Fourteen new employees receive Praxis stock awards covering 3,478 shares. - Stock Titan

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Praxis Precision Medicines: Still Potential Upside After Huge Rally (Rating Upgrade) - Seeking Alpha

Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st

Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st

(PRAX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Sixty-six new employees receive stock awards from Praxis. They vest over four years. - Stock Titan

Praxis Precision Medicines (PRAX) Climbs 1.23% as Shares Press Toward $375.69 Resistance - Rounding Top - careplusvn.com

PRAX Stock Price, Quote & News - Syfe

S&P 500 Futures Drop in Premarket Trading; Praxis Precision Meds, Science Applications Lead - Barron's

PMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities - Yahoo Finance

Breakeven On The Horizon For Praxis Precision Medicines, Inc. (NASDAQ:PRAX) - Moomoo

PRAX Maintains by Goldman Sachs -- Price Target Raised to $575 - GuruFocus

Praxis Precision Medicines Slides as Investors Appear to Lock In Gains After Recent Rally - Quiver Quantitative

Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $575 - Moomoo

Praxis (PRAX) Update: Climbs 1.92% to $376.94 for the Current Session; the Supplied Trading Band Runs From $358.09 to $395.79 - Percent Below MA - vinanet.vn

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock - Yahoo Finance

Praxis Precision Medicine Number of Employees 2026 | Employee Count & Headcount Data - reveliolabs.com

Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $650 - Moomoo

Praxis Precision Medicines (NASDAQ:PRAX) Hits New 1-Year High - What's Next? - MarketBeat

Praxis Precision Medicines (NASDAQ:PRAX) Trading 6.3% Higher - Still a Buy? - MarketBeat

Praxis Precision Medicines stock hits 52-week high at 388.27 USD - Investing.com Nigeria

Praxis Precision Medicines stock hits 52-week high at 388.27 USD - Investing.com

Praxis Precision Medicines stock hits 52-week high at 388.27 USD - Investing.com Canada

Praxis Precision Medicines Could Be Approaching 'Perfect Trifecta,' Oppenheimer Says - marketscreener.com

Raymond James Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $945 - Moomoo

Raymond James raises Praxis Precision Medicines price target on pipeline outlook By Investing.com - Investing.com Australia

Raymond James raises Praxis Precision Medicines price target on pipeline outlook - Investing.com Australia

Raymond James raises Praxis Precision Medicines price target on pipeline outlook - Investing.com India

Raymond James raises Praxis Precision Medicines price target on pipeline outlook - Investing.com

Praxis Precision Medicines (PRAX) Holds Near $366.81 as Consolidation Tightens Between Key Levels - Block Trade Flow - vinanet.vn

9,840 Shares in Praxis Precision Medicines, Inc. $PRAX Purchased by Handelsbanken Fonder AB - MarketBeat

Praxis Precision Medicines (PRAX): Orbis, Allan Gray disclose 5.5% ownership stake - Stock Titan

(PRAX) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Praxis (PRAX) Q2 2026 Earnings Call Transcript - AOL.com

Praxis Precision Medicines (NASDAQ:PRAX) Reaches New 12-Month High - Here's Why - MarketBeat

PRAX Stock Drops 12% After Hours On Trial Setback — Retail Eyes FDA Approval Of Other Pipeline Candidates - Stocktwits

Praxis Precision Medicines (PRAX) Edges Higher as Biotech Momentum Holds Above Key Support - Quality Factor - dars.gov.et

4 Biotech Stocks With Major Second-Half Pipeline Catalysts This Year - TradingView

Equities Analysts Offer Predictions for PRAX Q3 Earnings - MarketBeat

Praxis Precision Medicines (PRAX) Edges Higher as Biotech Momentum Holds Above Key Support - Weak Sell Signals - vinanet.vn

H.C. Wainwright Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,201 - Moomoo

PRAXに類似

ABVX$88.714.48%

AXSM$139.612.65%

ARWR$59.530.07%

CYTK$62.310.45%

CORT$81.931.83%